News

Promoting connectivity and exchange between young cancer researchers and clinicians: ESMO young oncologists meet the EACR

7 Nov 2014
Promoting connectivity and exchange between young cancer researchers and clinicians: ESMO young oncologists meet the EACR

Celebrated at the recent 2014 Congress of the European Society for Medical Oncology (ESMO), 26 – 28 September (Madrid, Spain), Joan Seoane, Director of Translational Research at VHIO and Member of the Executive Committee of the European Committee of the European Association of Cancer Research (EACR), and Leticia de Mattos-Arruda, Medical Oncologist and Investigator in Seoane´s Gene Expression & Cancer Group at VHIO, and Member of ESMO´s Young Oncologists Committee, worked together to help provide a novel educational platform especially tailored to young researchers and physician-scientists:

ESMO YOs (Young Oncologists) meet the EACR: Integrating basic science into clinical research.

This special workshop, co-Chaired by Raffaele Califano, ESMO´s Young Oncologists Committee Chair, and VHIO´s Leticia de Mattos-Arruda, provided a unique two-way opportunity for young scientists and clinicians in oncology to engage and exchange on and around current challenges and new directions in ultimately harnessing and translating latest research into improved cancer treatment and care as rapidly as possible.

Organised into four presentations expertly delivered by renowned leaders in cancer research and EACR members Joan Seoane (Spain), Carlos Caldas (UK), Klaus Pantel (Germany), and Timothy Yap (UK), each talk was flanked by a specially selected Session Shooter.

This progressive ESMO session undoubtedly represented an important step forward in promoting communication and creating synergies between young cancer researchers and physician-scientists.

ecancertv caught up with Joan Seoane straight after the meeting to find out more:

Click here to watch the ecancertv interview which not only covers the workshop itself but also addresses timely topics including the molecular mechanisms behind brain tumours and exciting novel biomarkers.

Source: Vall d'Hebron Institute